Invisible burden of COVID-19: enzyme replacement therapy disruptions.
Ayça Burcu KahramanYilmaz YildizKısmet ÇıkıHalil Tuna Akarİzzet ErdalAli DursunAyşegül TokatlıHatice Serap SivriPublished in: Journal of pediatric endocrinology & metabolism : JPEM (2021)
Interruption of ERT during the COVID-19 pandemic may have significant consequences. It may be beneficial to switch to home treatment or reserve dedicated facilities. With proper planning and management, the treatment disruptions of this particular group can be avoided.